Navigate to
-
GLP-1 pipeline FAQs FDA-approved 2025 2027 Drug name/Manufacturer/Dosage form semaglutide 1.7 mg & 2.4 mg (Wegovy)/Novo Nordisk/SC DISCLAIMER The drug pipeline is fluid; the dates and information...
-
Drug name/Manufacturer/Dosage form retatrutide/Eli Lilly/SC Drug name/Manufacturer/Dosage form semaglutide (Wegovy)/Novo Nordisk/SC tirzepatide (Zepbound)/Eli Lilly/SC T2DM Access the complete...
-
Drug name/Manufacturer/Dosage form orforglipron/Eli Lilly/oral retatrutide/Eli Lilly/SC T2DM Diabetic nephropathy (prevention in pts with T2DM & CKD) Alzheimers disease Are generic versions of...
-
2027 OSA + obesity/overweight 2028 Drug name/Manufacturer/Dosage form retatrutide/Eli Lilly/SC survodutide/Zealand & Boehringer Ingelheim/SC 2026 Drug name/Manufacturer/Dosage form...
-
Drug name/Manufacturer/Dosage form semaglutide (Wegovy)/Novo Nordisk/SC - FDA decision 4Q2025 tirzepatide (Zepbound)/Eli Lilly/SC - FDA submission withdrawn Drug name/Manufacturer/Dosage form...
-
T2DM 2026 Diabetic nephropathy (prevention in pts with T2DM & CKD) T1DM + obesity or overweight Drug name/Manufacturer/Dosage form retatrutide/Eli Lilly/SC Drug name/Manufacturer/Dosage form...
-
Download our table OSA + obesity or overweight T2DM Drug name/Manufacturer/Dosage form dulaglutide (Trulicity)/Eli Lilly/SC liraglutide (Victoza)/Novo Nordisk/SC semaglutide 1 mg & 2 mg...
-
Drug name/Manufacturer/Dosage form retatrutide/Eli Lilly/SC Besides Novo Nordisk and Eli Lilly, what other pharmaceutical companies have GLP1s in the pipeline in late-stage development?...